Revenue | ₹2.77Cr |
Net Profits | ₹0.23Cr |
Net Profit Margins | -8.30% |
Norris Medicines Ltd’s revenue jumped 82.24% since last year same period to ₹2.77Cr in the Q4 2024-2025. On a quarterly growth basis, Norris Medicines Ltd has generated 149.55% jump in its revenue since last 3-months.
Norris Medicines Ltd’s net profit fell -235.29% since last year same period to ₹0.23Cr in the Q4 2024-2025. On a quarterly growth basis, Norris Medicines Ltd has generated 17.86% jump in its net profits since last 3-months.
Norris Medicines Ltd’s net profit margin fell -174.24% since last year same period to -8.30% in the Q4 2024-2025. On a quarterly growth basis, Norris Medicines Ltd has generated 67.08% jumped in its net profit margins since last 3-months.
The revenue for Norris Medicines Ltd in the Q4 results 2024 was ₹2.77Cr.
The net profit for Norris Medicines Ltd in the Q4 results 2024 was ₹0.23Cr.
The net profit margin for Norris Medicines Ltd in the Q4 results 2024 was -8.30%.
The revenue for Norris Medicines Ltd in the Q4 results 2023 was ₹1.52Cr.
The net profit for Norris Medicines Ltd in the Q4 results 2023 was ₹0.17Cr.
The net profit margin for Norris Medicines Ltd in the Q4 results 2023 was 11.18%.